T. Huizinga
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies 549
- Systemic Lupus Erythematosus Research 355
- Immunology top 0.05%
- T-cell and B-cell Immunology 81
- Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research 107
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 115
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Monoclonal and Polyclonal Antibodies Research 225
-
- Lymphoma Diagnosis and Treatment 83
- Systemic Sclerosis and Related Diseases 70
- Co-authors
- René E. M. ToesAnnette H M van der Helm–van MilFrederick WolfeDavid L. ScottM. KloppenburgAndreea Ioan‐FacsinayCornelia F AllaartLeendert A. Trouw
- Cited by
- RheumatologyImmunologyHematology
- Journals
- Annals of the Rheumatic Diseases (267 papers)Lara D. Veeken (68 papers)Arthritis Research & Therapy (54 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
T. Huizinga
1.1k papers receiving 48.2k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Rheumatology 28.4k
- Immunology 14.7k
- Hematology 6.9k
- Genetics 4.0k
- Radiology, Nuclear Medicine and Imaging 8.5k
Countries citing papers authored by T. Huizinga
This map shows the geographic impact of T. Huizinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Huizinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Huizinga more than expected).
Fields of papers citing papers by T. Huizinga
This network shows the impact of papers produced by T. Huizinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Huizinga. The network helps show where T. Huizinga may publish in the future.
Co-authorship network
The 25 scholars most cited alongside T. Huizinga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 35 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 4 | |
| 11 | 2018 | 129 | |
| 12 | Effect of Etanercept on Several Soluble Biomarkers in a Randomized Controlled Trial of Patients with Erosive Hand Osteoarthritis | 2016 | 1 |
| 13 | 2015 | 86 | |
| 14 | Impact of Obesity on 1 Year Outcomes: Results from the Meteor Foundation International Rheumatoid Arthritis Cohort | 2014 | 2 |
| 15 | ASSESSMENT OF GLOBAL DISEASE ACTIVITY IN RA BY PATIENTS AND PHYSICIANS: CULTURAL DIFFERENCES ACROSS COUNTRIES IN THE METEOR DATABASE | 2014 | 1 |
| 16 | Evaluating MRI-Detected Tenosynovitis of the Hand and Wrist in Early Arthritis | 2014 | 2 |
| 17 | Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of the IL-6 Receptor: Effects On Hemoglobin Levels in a Clinical Trial for the Treatment of Moderate-to-Severe Rheumatoid Arthritis | 2012 | 1 |
| 18 | A Multi-Biomarker Disease Activity (Vectra DA) Algorithm Score for Rheumatoid Arthritis Predicts Radiographic Progression in the BeSt Study | 2011 | 1 |
| 19 | Remission Induction Therapy with Methotrexate and Prednisone in Patients with Early Rheumatoid and Undifferentiated Arthritis. | 2011 | 4 |
| 20 | 2004 | 71 |
About T. Huizinga
T. Huizinga is a scholar working on Rheumatology, Immunology and Genetics, having authored 1.1k papers that have together received 49.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (549 papers), Systemic Lupus Erythematosus Research (355 papers), Monoclonal and Polyclonal Antibodies Research (225 papers), Chronic Lymphocytic Leukemia Research (115 papers), Autoimmune and Inflammatory Disorders Research (107 papers), Lymphoma Diagnosis and Treatment (83 papers), T-cell and B-cell Immunology (81 papers) and Systemic Sclerosis and Related Diseases (70 papers). The work is most often cited by research in Rheumatology (28.4k citations), Immunology (14.7k citations) and Hematology (6.9k citations). T. Huizinga has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include René E. M. Toes, Annette H M van der Helm–van Mil, Frederick Wolfe, David L. Scott, M. Kloppenburg, Andreea Ioan‐Facsinay, Cornelia F Allaart, Leendert A. Trouw, Ferdinand C. Breedveld and Diane van der Woude. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Research & Therapy, RMD Open and Osteoarthritis and Cartilage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.